Shulman Joseph's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 19, 2025
- Accession no.
- 0001104659-25-015324
- Filed
- Feb 19, 2025
- Trade date
- Feb 14-19, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $70.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shulman JosephCIK 0001909855 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2025 | Common Stock | MOption exerciseAcquired | +4,125 | – | – | 9,737 | Direct | |
| Feb 19, 2025 | Common Stock | SSaleDisposed | −1,228 | $57.22 | −$70,266.16 | 8,509 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | AGrant or awardAcquired | +25,000 | $0.00 | $0 | 25,000 | Direct | |
| Feb 14, 2025 | Common Stock | AGrant or awardAcquired | +37,500 | $0.00 | $0 | 37,500 | Direct | |
| Feb 16, 2025 | Common Stock | MOption exerciseDisposed | −4,125 | $0.00 | $0 | 12,375 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.